全文获取类型
收费全文 | 4431512篇 |
免费 | 348695篇 |
国内免费 | 39383篇 |
专业分类
耳鼻咽喉 | 58551篇 |
儿科学 | 133235篇 |
妇产科学 | 110839篇 |
基础医学 | 667233篇 |
口腔科学 | 117767篇 |
临床医学 | 422934篇 |
内科学 | 775712篇 |
皮肤病学 | 107884篇 |
神经病学 | 356023篇 |
特种医学 | 171862篇 |
外国民族医学 | 705篇 |
外科学 | 648011篇 |
综合类 | 184206篇 |
现状与发展 | 108篇 |
一般理论 | 2530篇 |
预防医学 | 365438篇 |
眼科学 | 104850篇 |
药学 | 327659篇 |
459篇 | |
中国医学 | 34968篇 |
肿瘤学 | 228616篇 |
出版年
2022年 | 37248篇 |
2021年 | 72413篇 |
2020年 | 48880篇 |
2019年 | 68689篇 |
2018年 | 83486篇 |
2017年 | 66327篇 |
2016年 | 71037篇 |
2015年 | 90182篇 |
2014年 | 128283篇 |
2013年 | 191564篇 |
2012年 | 138676篇 |
2011年 | 145136篇 |
2010年 | 141873篇 |
2009年 | 140606篇 |
2008年 | 121599篇 |
2007年 | 126831篇 |
2006年 | 134665篇 |
2005年 | 129180篇 |
2004年 | 123362篇 |
2003年 | 113159篇 |
2002年 | 100944篇 |
2001年 | 152861篇 |
2000年 | 147388篇 |
1999年 | 138351篇 |
1998年 | 73053篇 |
1997年 | 69550篇 |
1996年 | 66968篇 |
1995年 | 62242篇 |
1994年 | 55847篇 |
1993年 | 51406篇 |
1992年 | 97212篇 |
1991年 | 93145篇 |
1990年 | 89300篇 |
1989年 | 87285篇 |
1988年 | 80352篇 |
1987年 | 78358篇 |
1986年 | 74460篇 |
1985年 | 72410篇 |
1984年 | 61806篇 |
1983年 | 55470篇 |
1982年 | 46127篇 |
1981年 | 43093篇 |
1980年 | 40650篇 |
1979年 | 53175篇 |
1978年 | 43782篇 |
1977年 | 39548篇 |
1976年 | 36021篇 |
1975年 | 36071篇 |
1974年 | 39043篇 |
1973年 | 37854篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
H J Kim C H Kang Y T Kim S-W Sung J H Kim S M Lee C-G Yoo C-T Lee Y W Kim S K Han Y-S Shim J-J Yim 《The European respiratory journal》2006,28(3):576-580
Although surgical lung resection could improve prognosis in some patients with multidrug-resistant tuberculosis (MDR-TB), there are no reports on the optimal candidates for this surgery. The aim of the present study was to elucidate the prognostic factors for surgery in patients with MDR-TB. Patients who underwent lung resection for the treatment of MDR-TB between March 1993 and December 2004 were included in the present study. Treatment failure was defined as greater than or equal to two of the five cultures recorded in the final 12 months of treatment being positive, any one of the final three cultures being positive, or the patient having died during treatment. The variables that affected treatment outcomes were identified through univariate and multivariate logistic regression analysis. In total, 79 patients with MDR-TB were included in the present study. The treatment outcomes of 22 (27.8%) patients were classified as failure. A body mass index <18.5 kg x m(-2), primary resistance, resistance to ofloxacin and the presence of a cavitary lesion beyond the range of the surgical resection were associated with treatment failure. Low body mass index, primary resistance, resistance to ofloxacin and cavitary lesions beyond the range of resection are possible poor prognostic factors for surgical lung resection in multidrug-resistant tuberculosis patients. 相似文献
993.
994.
Katharine R. Owen Mollie Donohoe Sian Ellard Andrew T. Hattersley 《Diabetic medicine》2003,20(10):823-827
Background Familial partial lipodystrophy (FPLD) is a monogenic form of diabetes characterised by a dominantly inherited disorder of adipose tissue associated with the loss of subcutaneous fat from the limbs and trunk, with excess fat deposited around the face and neck. The lipodystrophy causes severe insulin resistance, resulting in acanthosis nigricans, diabetes, dyslipidaemia, and increased risk of cardiovascular disease. Preliminary results from animals and man suggest that increasing subcutaneous fat by treatment with thiazolidinediones should improve insulin resistance and the associated features of this syndrome. Case report We report a 24-year-old patient with FPLD caused by a mutation in the LMNA gene (R482W) treated with 12 months of rosiglitazone. Subcutaneous fat increased following rosiglitazone treatment as demonstrated by a 29% generalised increase in skin-fold thickness. Leptin levels increased from 5.8 to 11.2 ng/ml. Compared with treatment on Metformin, there was an increase in insulin sensitivity (HOMA S% 17.2–31.6) but no change in glycaemic control. The lipid profile worsened during the follow-up period. Conclusion This initial case suggests that, for modification of cardiovascular risk factors, there are no clear advantages in treating patients with FPLD with rosiglitazone despite increases in subcutaneous adipose tissue. Larger series will be needed to identify moderate beneficial effects and treatment may be more effective in patients with generalised forms of lipodystrophy. 相似文献
995.
996.
肱骨骨不连的手术治疗 总被引:4,自引:0,他引:4
目的探讨肱骨骨不连的手术治疗方法及疗效。方法1998年12月~2005年5月共收治肱骨骨不连患者25例,均为肱骨骨折内固定术后发生骨不连,其中3例并发骨髓炎,6例合并不同程度肱骨骨缺损,骨缺损长度为3~6cm。骨不连病程8个月~5年。15例行吻合血管游离腓骨移植,10例采用加压交锁髓内针进行肱骨固定并辅以自体骨植骨。结果术后25例均得到随访,时间6个月~6年2个月。吻合血管游离腓骨移植组中移植的腓骨段均与肱骨干形成骨性愈合,平均骨性愈合时间为3.1个月;交锁髓内针组平均骨愈合时间为3.8个月。按Crates和Whittle肩肘关节功能评价标准,腓骨移植组:优9例,良4例,差2例;交锁髓内针组:优5例,良3例,差2例。结论应用加压交锁髓内针辅以自体骨移植对硬化性肱骨骨不连是一种有效的外科治疗方法;对合并骨髓炎、大段骨缺损及严重骨质疏松的肱骨骨不连,采用吻合血管游离腓骨移植可一期进行修复与重建。 相似文献
997.
998.
Pancreatic Panniculitis Associated with Allograft Pancreatitis and Rejection in a Simultaneous Pancreas–Kidney Transplant Recipient 总被引:1,自引:0,他引:1
J. L. Pike J. C. Rice R. L. Sanchez E. B. Kelly B. C. Kelly 《American journal of transplantation》2006,6(10):2502-2505
Pancreatic panniculitis is an uncommon condition that can occur in association with pancreatic disease. We present a case of pancreatic panniculitis in a female pancreas-kidney transplant recipient 5 months post-transplant. The patient was on standard immunosuppressive medications and had acute rejection of her renal allograft. The diagnosis of allograft pancreatitis and rejection presenting with pancreatic panniculitis was supported clinically, histopathologically and by laboratory and imaging data. This is the fourth case of pancreatic panniculitis occurring in a transplant recipient and the first in a simultaneous pancreas-kidney transplant recipient. It is also the first case associated with allograft rejection. Clinicians should be aware that pancreatic panniculitis may be a manifestation of underlying allograft pancreatic disease. 相似文献
999.
K. Dahan V. Audard F. Roudot-Thoraval D. Desvaux M. Abtahi H. Mansour M. Kumal P. Lang P. Grimbert 《American journal of transplantation》2006,6(7):1725-1730
The clinical outcome and appropriate management for patients showing 'borderline changes' on allograft biopsy after renal transplantation is still controversial. In an attempt to identify predictive factors of clinical outcome of patients with such lesions, we reviewed the clinical course of 91 patients with borderline changes. Multivariate analysis revealed significant and independent effects of histological stage (i + t < or = or > 2) and time to borderline changes (< or = or > 3 months after transplant) on serum creatinine levels at 1 year from borderline changes episodes (respectively, p = 0.04 and p = 0.02) and only a significant effect of time to borderline changes on serum creatinine levels at 2 years (p = 0.005). Renal function at 1 year and 2 years as 5- and 8-year graft survival were not significantly different in the group of patients treated with antirejection therapy (T group, n = 49) compared with the untreated group (UT group, n = 42). This study strongly suggests that borderline changes with histological score (i + t) > 2 and late episodes of borderline changes should be considered to be of poor prognosis. 相似文献
1000.
J. F. Trotter J. Campsen T. Bak M. Wachs L. Forman G. Everson I. Kam 《American journal of transplantation》2006,6(8):1882-1889
The purpose of this study is to determine the role of liver biopsy and outcome of patients undergoing donor evaluation for adult-to-adult right hepatic lobe living donor liver transplantation (LDLT). Records of patients presenting for a comprehensive donor evaluation between 1997 and February 2005 were reviewed. Liver biopsy was performed only in patients with risk factors for abnormal histology. Two hundred and sixty patients underwent a comprehensive donor evaluation and 116 of 260 (45%) were suitable for donation, 14 of 260 (5.4%) did not complete evaluation and 130 of 260 (50%) were rejected. Four patients underwent unsuccessful hepatectomy surgery due to discovery of intraoperative abnormalities. Between 1997 and 2001, the acceptance rate of donor candidates (63%) was higher than 2002-2005 (36%), p < 0.0001. Sixty-six of the 150 eligible patients (44%) fulfilled criteria for liver biopsy and 28 of 66 (42%) had an abnormal finding. Less than half of the patients undergoing donor evaluation were suitable donors and the donor acceptance rate has declined over time. A large proportion of the patients undergoing liver biopsy have abnormal findings. Our evaluation process failed to identify 4 of 103 who had aborted donor surgeries. 相似文献